Lehigh Valley school leaders say online testing, middle-school math alignment impacted test scores

Test results show a tale of two school systems across the Lehigh Valley, with suburban districts Southern Lehigh and Parkland ...
The Kenya Times on MSN

National and extra-county senior schools to offer core mathematics, CRE, and geography to grade 10 students [list]

The Competency-Based Curriculum (CBC) at the senior school level (Grades 10–12) introduces structured pathways, subjects, and ...
MyJoyOnline

2025 WASSCE results: Nearly 1 out of 4 candidates failed Core Mathematics and Social Studies

The West African Examinations Council (WAEC) has confirmed a national education concern with the release of the provisional WASSCE 2025 results, revealing a worrying surge in the outright failure rate ...
Benzinga.com

Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards'

Culper Research report argues that the data underpinning its essential tremor program cannot withstand regulatory scrutiny. According to the short report, Praxis engineered its October 2025 results ...
The Daily Signal

Thanks to the Woke Math Movement, Some Freshmen at UCSD Can’t Do Grade-Level Math

A new report from the University of California, San Diego has ignited a viral conversation on social media, because it demonstrates the alarming lack of preparation among incoming freshmen for college ...
Newsweek

Students at California University Without 8th Grade Math Skills Skyrockets

A sharp rise in students entering the University of California system without middle school-level math skills is raising alarms among educators. A new internal report from the University of California ...
Seeking Alpha

Praxis: Back From The Dead, Ulixacaltamide Returns In Essential Tremor With Caveats

Praxis Precision Medicines surged after positive Essential3 data for ulixacaltamide in essential tremor, but tolerability issues limit enthusiasm. Ulixacaltamide demonstrated functional benefit, but ...
MarketWatch

Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.

Shares of biopharmaceutical company Praxis Precision Medicines Inc. soared Thursday, boosted by the successful trial of a new drug to treat movement disorders. The drug, ulixacaltamide, targets ...
MedCity News

Persistence Pays Off for Praxis as Essential Tremor Drug Succeeds in Two Pivotal Studies

Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...
Reuters

Praxis surges as drug improves daily function for movement disorder patients in trials

Oct 16 (Reuters) - Praxis Precision Medicines (PRAX.O), opens new tab said on Thursday its experimental drug for a type of movement disorder improved patients' ability to perform daily tasks in two ...
FierceBiotech

Praxis erases doubts with phase 3 wins in essential tremor, sending shares soaring

Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. After brushing off a recommendation to end a phase 3 study earlier this year based on ...
Yahoo Finance

Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase 3 Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor

BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...